Axa Portfolio holdings
AUM
$34.8B
1-Year Return
21.93%
This Quarter Return
+17.13%
1 Year Return
+21.93%
3 Year Return
+101.72%
5 Year Return
+168.92%
10 Year Return
+430.37%
AUM
$31.9B
AUM Growth
+$4.19B
(+15%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
0.04%
Top 10 Holdings %
Top 10 Hldgs %
18.87%
Holding
1,400
New
111
Increased
494
Reduced
445
Closed
146
Top Buys
| 1 |
Amazon
AMZN
|
+$85.7M |
| 2 |
Tesla
TSLA
|
+$80.1M |
| 3 |
SPDR S&P China ETF
GXC
|
+$75.6M |
| 4 |
QuidelOrtho
QDEL
|
+$61.2M |
| 5 |
Pinduoduo
PDD
|
+$55.2M |
Top Sells
| 1 |
Linde
LIN
|
+$159M |
| 2 |
Lemonade
LMND
|
+$93M |
| 3 |
Honeywell
HON
|
+$79.7M |
| 4 |
IBM
IBM
|
+$68.7M |
| 5 |
Intel
INTC
|
+$64.6M |
Sector Composition
| 1 | Technology | 30.91% |
| 2 | Healthcare | 17.61% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Financials | 10.48% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Stantec
STN
$12.4B
| $1.58M | 0.01% |
+48,700
| New | +$1.58M |
|
877
Dover
DOV
$24.1B
| $1.58M | 0.01% |
12,496
+1,340
| +12% | +$169K |
|
878
CytomX Therapeutics
CTMX
$341M
| $1.57M | ﹤0.01% |
239,650
+78,524
| +49% | +$514K |
|
879
Arrowhead Research
ARWR
$3.99B
| $1.57M | ﹤0.01% |
20,400
| – | – |
|
880
Euronet Worldwide
EEFT
$3.57B
| $1.57M | ﹤0.01% |
+10,800
| New | +$1.57M |
|
881
Invesco CurrencyShares Euro Currency Trust
FXE
$529M
| $1.55M | ﹤0.01% |
13,493
| – | – |
|
882
Healthpeak Properties
DOC
$12.5B
| $1.52M | ﹤0.01% |
50,390
+15,387
| +44% | +$465K |
|
883
Neurocrine Biosciences
NBIX
$14B
| $1.52M | ﹤0.01% |
15,841
-54,215
| -77% | -$5.2M |
|
|
HR
884
DELISTED
Healthcare Realty Trust Incorporated
HR
| $1.52M | ﹤0.01% |
51,290
| – | – |
|
885
Occidental Petroleum
OXY
$45.6B
| $1.51M | ﹤0.01% |
87,222
-55,847
| -39% | -$967K |
|
886
MDU Resources
MDU
$3.36B
| $1.51M | ﹤0.01% |
150,429
| – | – |
|
|
BZUN
887
Baozun
BZUN
$230M
| $1.49M | ﹤0.01% |
43,500
+9,547
| +28% | +$328K |
|
|
EQC
888
DELISTED
Equity Commonwealth
EQC
| $1.49M | ﹤0.01% |
54,719
+17,500
| +47% | +$477K |
|
889
Crown Holdings
CCK
$11B
| $1.48M | ﹤0.01% |
14,800
-3,500
| -19% | -$351K |
|
|
TPCO
890
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $1.47M | ﹤0.01% |
107,298
+8,800
| +9% | +$121K |
|
891
Telephone and Data Systems
TDS
$4.45B
| $1.44M | ﹤0.01% |
77,400
-89,000
| -53% | -$1.65M |
|
892
Ovid Therapeutics
OVID
$88.9M
| $1.43M | ﹤0.01% |
620,402
+25,735
| +4% | +$59.4K |
|
893
Schlumberger
SLB
$53.9B
| $1.43M | ﹤0.01% |
65,643
-31,302
| -32% | -$683K |
|
894
Graphic Packaging
GPK
$6.14B
| $1.42M | ﹤0.01% |
84,000
| – | – |
|
895
Materion
MTRN
$2.29B
| $1.42M | ﹤0.01% |
22,200
-1,100
| -5% | -$70.1K |
|
896
FTI Consulting
FCN
$5.23B
| $1.41M | ﹤0.01% |
12,600
-24,700
| -66% | -$2.76M |
|
897
Grand Canyon Education
LOPE
$5.69B
| $1.39M | ﹤0.01% |
14,900
| – | – |
|
898
Digital Realty Trust
DLR
$59.3B
| $1.38M | ﹤0.01% |
9,851
-15,900
| -62% | -$2.22M |
|
899
Voyager Therapeutics
VYGR
$231M
| $1.36M | ﹤0.01% |
189,700
-1,800
| -0.9% | -$12.9K |
|
900
Workiva
WK
$4.24B
| $1.35M | ﹤0.01% |
14,700
-1,300
| -8% | -$119K |
|